Bicycle Therapeutics

NASDAQ: BCYC · Real-Time Price · USD
7.49
0.11 (1.49%)
At close: Aug 15, 2025, 1:07 PM

Bicycle Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
35.27M 26.98M 14.46M 11.7M
Cost of Revenue
172.97M 156.5M 3.69M 44.88M
Gross Profit
-137.69M -129.52M -67.15M -33.18M
Operating Income
-209.87M -189.95M -116.65M -65.62M
Interest Income
34.28M 14M 5.76M 120K
Pretax Income
-173.8M -179.21M -114.24M -68.48M
Net Income
-169.03M -180.66M -112.72M -66.82M
Selling & General & Admin
71.46M 59.83M 49.51M 32.44M
Research & Development
172.97M 156.5M 81.61M 44.88M
Other Expenses
-172.25M -155.9M -81.61M n/a
Operating Expenses
72.18M 60.43M 49.51M 77.31M
Interest Expense
1.73M 3.26M 3.34M 2.98M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
245.15M 216.92M 131.12M 77.31M
Income Tax Expense
-4.76M 1.46M -1.52M -1.66M
Shares Outstanding (Basic)
58.21M 35.59M 29.66M 25.06M
Shares Outstanding (Diluted)
58.21M 35.59M 29.66M 25.06M
EPS (Basic)
-2.91 -5.08 -3.8 -2.67
EPS (Diluted)
-2.9 -5.08 -3.8 -2.67
EBITDA
-164.89M -183.4M -112.96M -64.08M
EBIT
-172.07M -189.95M -116.65M -65.5M
Depreciation & Amortization
7.18M 6.55M 3.69M 1.41M